IDiyas

For the Inventor, By the Inventor

Dewitt, NY, United States of America

Ronnie R Crenshaw

USPTO Granted Patents = 47

Average Co-Inventor Count = 2.1

ph-index = 13

Forward Citations = 568(Granted Patents)


Company Filing History:

goldMedal46 out of 637 
 
Bristol-myers Company
 patents
silverMedal1 out of 3,681 
 
Bristol-myers Squibb Compnay
 patents

Years Active: 1977-1997

Loading Chart...
47 patents (USPTO):Explore Patents
1. 5618816 - Antimigraine 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl and (1997-04-08),
2. 4788184 - Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents (1988-11-29),
3. 4692531 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1987-09-08),
4. 4644006 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1987-02-17),
5. 4607105 - 3-cyclobutene-1,2-dione intermediates (1986-08-19),
6. 4600779 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1986-07-15),
7. 4595758 - Ethanediimidamide intermediates (1986-06-17),
8. 4588826 - Ethanediimidamide intermediates (1986-05-13),
9. 4578471 - Substituted amino alkyl pyridyl ethanediimidamides (1986-03-25),
10. 4546188 - Substituted 1,2-diaminocyclobutene-3,4-diones (1985-10-08),
11. 4539316 - Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones (1985-09-03),
12. 4528378 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1985-07-09),
13. 4528377 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1985-07-09),
14. 4528375 - Substituted 3,4-diamino-1,2,5-thiadiazoles having histamine H.sub.2 (1985-07-09),
15. 4526973 - Chemical compounds (1985-07-02),

Title: The Innovations of Ronnie R. Crenshaw

Introduction

Ronnie R. Crenshaw, a prolific inventor based in Dewitt, NY, has made significant contributions to the field of pharmaceutical sciences, particularly with his extensive work in developing innovative compounds for various medical applications. With a remarkable portfolio of 47 patents, Crenshaw has focused primarily on innovative approaches to addressing conditions such as migraines and ulcers.

Latest Patents

Among his latest patents, Crenshaw has introduced novel 1,2,5-thiadiazole derivatives of indolylalkyl-pyridnyl aimed at alleviating vascular headaches. These compounds offer a potential breakthrough in the treatment of migraines, demonstrating his commitment to advancing therapeutic options. Furthermore, he developed a series of substituted 3-cyclobutene-1,2-diones as anti-ulcer agents, which serve as intermediates in the preparation of histamine H2-antagonist anti-ulcer compounds. The intricate design of these formulas showcases his innovative approach to pharmaceutical research, focusing on enhancing patient care.

Career Highlights

Crenshaw's career is marked by impressive affiliations with reputable companies such as Bristol-Myers Company and Bristol-Myers Squibb Company, where he has contributed his expertise in drug development. His innovative ideas have not only led to the filing of numerous patents but have also played a pivotal role in advancing medical treatments.

Collaborations

Throughout his career, Crenshaw has collaborated with fellow researchers and inventors like Aldo A. Algieri and Richard A. Partyka. These partnerships have fostered a dynamic exchange of ideas and have been instrumental in the development of groundbreaking pharmaceutical solutions.

Conclusion

Ronnie R. Crenshaw stands out as an accomplished inventor whose work in pharmaceuticals reflects a deep commitment to innovation and improving healthcare. With a proven track record of successful patents and collaborations, Crenshaw continues to inspire future generations of inventors in the realm of medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…